Roche
RO.SW
#38
Rank
$344.31 B
Marketcap
$432.76
Share price
1.37%
Change (1 day)
34.43%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: $20.44

According to Roche's latest financial reports the company's current EPS (TTM) is $20.44. In 2025 the company made an earnings per share (EPS) of $20.44 an increase over its 2024 EPS that were of $11.50.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025$20.4477.67%
2024$11.50-32.84%
2023$17.131.95%
2022$16.80-6.29%
2021$17.93-5.53%
2020$18.9816.56%
2019$16.2830.3%
2018$12.4920.22%
2017$10.39-5.81%
2016$11.034.62%
2015$10.55-5.13%
2014$11.12-25.05%
2013$14.8321.73%
2012$12.183.82%
2011$11.748.16%
2010$10.8523.72%
2009$8.77-12.31%
2008$10.00-0.34%
2007$10.0432.13%
2006$7.5942.56%
2005$5.33-22.7%
2004$6.89132.85%
2003$2.96-148.05%
2002-$6.16-209.09%
2001$5.65-57.03%
2000$13.1453.29%
1999$8.5731.24%
1998$6.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.74-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.02-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$1.31-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.61-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$14.48-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.56-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
$5.46-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$3.56-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.89-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK